Ethylamine

Ethylamine

SCHEMBL4346377

CCN.CS(=O)(O)=S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiosulfuric Acid SCHEMBL5146406 0.90
Thiosulfuric Acid SCHEMBL11412385 0.90 BLM (0.40)
Ethylamine SCHEMBL6138422 0.86
Propane SCHEMBL9442322 0.86
SCHEMBL5417020 0.83 PTGS1 (0.33)
Sulfuric Acid SCHEMBL921788 0.82
Sulfuric Acid SCHEMBL3677190 0.82 CA5A (0.50)
Sulfuric Acid SCHEMBL8766489 0.82 CA5A (0.50)
SCHEMBL7782660 0.82
SCHEMBL284772 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016116281-A1 ANTIVIRAL AGENTS IMMUNOLOGIK GMBH (DE) 2016-07-28 WO disclosed
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
US-20140349969-A1 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES AG (AT) 2014-11-27 US disclosed
EP-2674161-A1 FMO3 inhibitors for treating pain Akron Molecules GmbH (AT) 2013-12-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
US-20130252924-A1 Compounds and Methods for Treating Pain AKRON MOLECULES GMBH (AT) 2013-09-26 US disclosed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed
EP-1141335-B1 CHEMICALLY MODIFIED ENZYMES WITH MULTIPLE CHARGED VARIANTS GENENCOR INT (US) 2009-08-05 EP disclosed
US-7371553-B2 Chemically modified enzymes with multiple charged variants GENENCOR INTERNATIONAL, INC. (US) 2008-05-13 US disclosed
US-20030153020-A1 Identification of sortase gene NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-08-14 US disclosed
WO-2003020885-A2 IDENTIFICATION OF SORTASE GENE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-03-13 WO disclosed
US-20030022178-A1 Identification of sortase gene NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-30 US disclosed
US-20020127695-A1 Chemically modified enzymes with multiple charged variants GENENCOR INTERNATIONAL, INC. 2002-09-12 US disclosed
EP-1233780-A1 IDENTIFICATION OF SORTASE GENE The Regents of the University of California (US) 2002-08-28 EP disclosed
US-6379942-B1 SUBTILISIN ENZYME, WITH CYSTEINE RESIDUES AT GIVE AMINO ACID SEQUENCE POSITIONS, WHERE THE THIOL HYDROGEN IN THE CYSTEINE RESIDUE IS REPLACED, PROVIDING A SIDE CHAIN IWTH A MULTIPLY CHARGED MOIETY; DETERGENTS GENENCOR INTERNATIONAL, INC. 2002-04-30 US disclosed
EP-1141335-A2 CHEMICALLY MODIFIED ENZYMES WITH MULTIPLE CHARGED VARIANTS GENENCOR INTERNATIONAL, INC. (US) 2001-10-10 EP disclosed
WO-2000062804-A2 IDENTIFICATION OF SORTASE GENE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-10-26 WO disclosed
WO-2000037658-A2 CHEMICALLY MODIFIED ENZYMES WITH MULTIPLE CHARGED VARIANTS GENENCOR INTERNATIONAL, INC. (US) 2000-06-29 WO disclosed
WO-1999009145-A1 IDENTIFICATION OF SORTASE GENE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-02-25 WO disclosed